Skip to main content
. Author manuscript; available in PMC: 2015 Feb 23.
Published in final edited form as: Ann Surg Oncol. 2011 Sep 27;18(11):3164–3173. doi: 10.1245/s10434-011-1920-z

TABLE 3.

Multivariate Cox proportional hazard model for LRRFS

Characteristic All patients BCT Mastectomy



HR 95% CI P-value HR 95% CI P-value HR 95% CI P-value
Mastectomy vs. BCT 1.07 0.86 to 1.34 0.55
Age: >50 vs. ≤ 50 years 0.73 0.58 to 0.92 0.007 0.66 0.46 to 0.92 0.016 0.79 0.58 to 1.07 0.13
Tumor size: T2–4 vs. T1 1.37 1.09 to 1.72 0.006 1.35 0.98 to 1.86 0.07 1.39 1 to 1.92 0.048
Lymph nodes: N1–3 vs. N0 1.21 0.96 to 1.53 0.11 1.48 1.05 to 2.07 0.025 1.02 0.73 to 1.42 0.91
Grade: III vs. I/II 1.92 1.28 to 2.89 0.002 1.89 0.99 to 3.63 0.05 1.94 1.15 to 3.27 0.013
LVI: positive vs. negative/unknown 1.93 1.54 to 2.42 <0.0001 2.00 1.43 to 2.79 <0.0001 1.99 1.46 to 2.71 <0.0001
Resection margin: close/positive vs. free 1.89 1.37 to 2.6 <0.0001 2.02 1.32 to 3.1 0.001 1.86 1.14 to 3.03 0.013
Adjuvant chemotherapy: anthracycline or taxane vs. anthracycline + taxane 1.02 0.80 to 1.30 0.88 1.31 0.91 to 1.87 0.14 0.85 0.61 to 1.18 0.32
Adjuvant chemotherapy:other vs. anthracycline + taxane 2.01 1.46 to 2.77 <0.0001 1.72 1.03 to 2.89 0.038 2.24 1.47 to 3.4 0.0002